76
Views
15
CrossRef citations to date
0
Altmetric
Original

Radical scavenging and NO-releasing properties of selected β-adrenoreceptor antagonists

, , , , , , , & show all
Pages 741-752 | Received 11 Jan 2006, Published online: 07 Jul 2009
 

Abstract

It is claimed that novel β-adrenolytic drugs possess superior antioxidant properties as compared to classical selective or non-selective β-adrenoceptor antagonists. Here we tested this notion by analyzing radical scavenging properties of selected β-adrenolytic drugs and their ability to release nitric oxide in biological preparations. Selective β1-adrenolytics such as nebivolol, atenolol, metoprolol and non-selective β-adrenolytics with α1-receptor blocking properties such as carvedilol and labetalol were chosen for analysis. NO-releasing properties of nebivolol and carvedilol distinguished third generation β-adrenolytics from their older counterparts while the reactivity towards hydroxyl and peroxyl radicals discerns only carvedilol but not nebivolol. Thus, superior clinical efficacy of third generation β-adrenolytics may be related to their ability to release NO rather then to their direct antioxidant properties.

Notes

Tel: 48 12 4211168. Fax: 48 12 4217217. [email protected].

Tel: 48 42 6313096. Fax: 48 42 6365008. [email protected].

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 940.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.